___

1. Crenshaim TL, Goldsberg JP. Sexual Aspects of Neurochemistry: In Goldberg JP (editor). Sexual Pharmacology. New York: WW Norton & Company, 1996, 273-307.

2. Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI- associated sexual dysfunction in women at midlife. Climacteric 2012; 15:306-316.

3. Tufan AE, Ozten E, Isik S, Cerit C. Discerning the effects of psychopathology and antidepressant treatment on sexual dsyfunction. Int J Psychiatry Clin Pract 2013; 17:223-226.

4. Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009; 29:157-164.

5. Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006; 16:391-402.

6. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E. Bupropion: a review of its mechanism of antideressant activity. J Clin Psychiatry 1995; 56:395-401.

7. Stahl SM. Stahl’s Essential Psychopharmacology. Second ed., Cambridge: Cambridge University Press, 2000; 207-211.

8. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26:25-40.

9. Soykan A. The reliability and validity of Arizona Sexual Experiences Scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res 2004; 16:531-534.

10. Segraves RT. Effect of psychotrophic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989; 46:275-284.

11. Baldwin DS, Birtwistle J. Antidepressant Drugs And Sexual Function: Improving The Recognition And Management Of Sexual Dysfunction In Depressed Patients: IN Briley M, Montgomery S (editors). Antidepressant Therapy At The Dawn Of The Third Millenium. London: Martin Dunitz Ltd., 1998, 231-253.

12. Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRI induced sexual dysfunction. Perspect Psychiatr Care 2002; 38:111-116.

13. Uzbay T, Yuksel N. Antidepressants and sexual dysfunctions. Clinical Psychiatry 2004; 3:14-24 (in Turkish).

14. Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998; 59:112-115.

15. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo- controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor induced sexual dysfunction. J Clin Psychiatry 2004; 65:62-67.

16. Zajecka J. Strategies for the treatment of antidepressant related sexual dysfunction. J Clin Psychiatry 2001; 62 (Suppl. 3):35-43.

17. Mas M, Rodriguez del Castillo A, Guerra M, Davidson JM, Battaner E. Neurochemical correlates of male sexual behavior. Physiol Behav 1987; 41:341-342.

18. Hull EM, Eaton RC, Moses J, Lorrain D. Copulation increases dopamine activity in the medial preoptic area of male rats. Life Sci 1993; 52:935-940.

19. Verma S, Chhina GS, Mohan V, Singh B. Inhibition of male sexual behavior by serotonin application in ther medial preoptic area. Physiol Behav 1989; 46:327-330.

20. DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 2005; 66:844-888.

21. Labbate LA,Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 1997; 9:241-245.

22. Chollet CA, Andreatini R. Effect of bupropion on sexual dysfunction induced by fluoxetine: a case report of hypersexuality. J Clin Psychiatry 2003; 64:1268-1269.

23. Safarinejad MR. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. BJU Int 2010; 106:840-847.